We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

173 hedge funds and large institutions have $2.84B invested in Ionis Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 173 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more call options, than puts

Call options by funds: $36M | Put options by funds: $29.5M

Holders
173
Holders Change
+173
Holders Change %
–
% of All Funds
5.65%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
173
Increased
–
Reduced
–
Closed
–
Calls
$36M
Puts
$29.5M
Net Calls
+$6.51M
Net Calls Change
+$6.51M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
26
Visium Asset Management
New York
$19M +$15M +706,804 New
SNC
27
Stifel Nicolaus & Co
Missouri
$18.1M +$14.3M +674,192 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$17.6M +$13.9M +654,705 New
TCIM
29
TIAA CREF Investment Management
New York
$14M +$11.1M +522,714 New
MG
30
Meditor Group
Bermuda
$14M +$11.1M +520,000 New
Geode Capital Management
31
Geode Capital Management
Massachusetts
$13.1M +$10.4M +487,622 New
Norges Bank
32
Norges Bank
Norway
$13M +$10.3M +483,296 New
Goldman Sachs
33
Goldman Sachs
New York
$11.8M +$9.31M +437,700 New
Charles Schwab
34
Charles Schwab
California
$11.7M +$8.75M +411,600 New
MCM
35
Montibus Capital Management
Oregon
$10.6M +$8.36M +392,962 New
OAM
36
Oxford Asset Management
United Kingdom
$9.7M +$7.67M +360,836 New
Invesco
37
Invesco
Georgia
$8.77M +$6.94M +326,422 New
WHI
38
William Harris Investors
Illinois
$8.76M +$6.93M +325,834 New
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$8.13M +$6.43M +302,504 New
BIM
40
BlackRock Investment Management
Delaware
$7.99M +$6.32M +297,376 New
BIM
41
Bogle Investment Management
Massachusetts
$7.92M +$6.26M +294,607 New
BG
42
BlackRock Group
United Kingdom
$7.7M +$6.1M +286,683 New
EA
43
Emerald Advisers
Pennsylvania
$7.33M +$5.8M +272,927 New
Dimensional Fund Advisors
44
Dimensional Fund Advisors
Texas
$7.07M +$5.59M +263,021 New
CS
45
Credit Suisse
Switzerland
$6.71M +$5.31M +249,855 New
BBA
46
Baker Bros. Advisors
New York
$6.64M +$5.25M +247,036 New
ARTA
47
A.R.T. Advisors
New York
$5.4M +$4.27M +200,921 New
QBFM
48
QS Batterymarch Financial Management
New York
$5.32M +$4.21M +197,800 New
Deutsche Bank
49
Deutsche Bank
Germany
$5.3M +$4.19M +197,162 New
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$5.26M +$4.16M +195,714 New
1
2
3 4 5

IONS Hedge Fund Activity: Q2 2013 in Review

173 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2013, worth a combined $2.84B.

Buyers outnumbered sellers: 173 funds opened new IONS positions and 0 closed out — a net gain of 173 holders — while 0 added to existing stakes and 0 trimmed.

  • 173 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.84B of Ionis Pharmaceuticals stock for Q2 2013.
  • 173 funds opened new Ionis Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +173 holders.

Based on aggregated 13F filings for Q2 2013.